San Francisco Bay Area biotech stories.
Wednesday, March 14, 2012
Merck unit, Numerate ink heart drug design deal
A subsidiary of drug giant Merck and Numerate Inc., a San Bruno company tapping algorithms in drug design, will work together to find potential drug leads for a cardiovascular disease.
Share to Twitter
Share to Facebook
Post a Comment
Post Comments (Atom)